Conference Coverage: ESMO 2024 – Focus on Gynecologic Malignancies

Expert perspectives and strategic insights on the latest therapeutic developments and translational research coming out of ESMO regarding gynecologic malignancies.

October 10, 2024
Purchase Report

Faculty Chair

Kathleen Moore, MD

OU Health Stephenson Cancer Center, Oklahoma City, OK, USA

FACULTY MEMBERS

Brian Slomovitz, MD
Florida International University, Miami, FL, USA

Isabelle Ray-Coquard, MD, PhD
Comprehensive Cancer Centre Leon Bérard, Lyon, France

Bradley J. Monk, MD, FACS, FACOG
University of Arizona College of Medicine, Phoenix, AZ, USA

Mansoor Mirza, MD
Copenhagen University Hospital, Copenhagen, Denmark

Christina Fotopoulou, MD, PhD
Imperial College London, UK

Sample Report

Start discovering the insights

View Report

KEY TAKEAWAYS AND STRATEGIC INSIGHTS

  • Advanced Ovarian Cancer: Current Practices and Evolving Treatment Paradigms – Maintenance Therapy Today and Tomorrow
  • Advanced Ovarian Cancer: Current Practices and Evolving Treatment Paradigms – Treatment Modalities
  • Relapsed/Refractory Ovarian Cancer: Platinum Sensitive/Resistant
  • Advanced or Metastatic Endometrial Cancer: Current and Emerging Treatment Strategies
  • Advanced or Metastatic Cervical Cancer: Current Treatment and Future Directions

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.